Stay updated on Tivozanib Plus Nivolumab in RCC: Clinical Trial
Sign up to get notified when there's something new on the Tivozanib Plus Nivolumab in RCC: Clinical Trial page.

Latest updates to the Tivozanib Plus Nivolumab in RCC: Clinical Trial page
- Check3 days agoChange DetectedThe site footer revision identifier was updated from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check10 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check17 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record, indicating restricted access to the content.SummaryDifference18%

- Check31 days agoChange DetectedThe page now shows Revision: v3.7.0, indicating a new version of the study page was published, replacing the previous Revision: v3.6.6. This is a maintenance/versioning update and does not modify the study content.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page no longer displays a banner about a site outage or the intermittent delays notice, removing visible communication about ongoing service issues. This changes how users perceive the site's availability when viewing the study details.SummaryDifference0.1%

- Check66 days agoChange DetectedAn outage notice is now displayed across the site, warning of intermittent delays in NCBI services. The page revision has been updated to version v3.6.5, replacing the previous v3.6.4.SummaryDifference0.2%

Stay in the know with updates to Tivozanib Plus Nivolumab in RCC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tivozanib Plus Nivolumab in RCC: Clinical Trial page.